Economics of end-of-life care in the intensive care unit

P. Pronovost, D. C. Angus

Research output: Contribution to journalArticle

Abstract

End-of life care is in need of improvement, yet little is known about the effectiveness or cost of various end-of-life therapies. Economic analyses are used to help make decisions between two or more therapies when resources are constrained. In this chapter, we review the various types of economic analyses, the costs of dying, and how healthcare reform has impacted these costs. Finally, we discuss the unique issues associated with cost-effectiveness studies of palliative therapy, with emphasis on the problem of calculating a cost-effectiveness ratio when there is no good measurement for valuing the quality of death. It is likely that methods for conducting a cost-effectiveness analyses for end-of-life care will need to evolve or alternative strategies such as cost-benefit analysis or distributive justice will be needed to inform resource allocation decisions. As the national debate about healthcare costs, access, and quality continues, we will increasingly turn to economic analyses to help make resource allocation decisions. Cost-effectiveness analysis will continue to be the most popular form of economic analysis because it combines the results (effectiveness of treatment) with the costs of achieving the results. We must be aware of the limitations of cost-effectiveness analyses and the need for value judgments when using cost-effectiveness analyses to inform healthcare decisions.

Original languageEnglish (US)
JournalCritical Care Medicine
Volume29
Issue number2 SUPPL.
StatePublished - 2001

Fingerprint

Terminal Care
Cost-Benefit Analysis
Intensive Care Units
Economics
Resource Allocation
Health Care Costs
Costs and Cost Analysis
Health Care Reform
Social Justice
Palliative Care
Delivery of Health Care
Therapeutics

Keywords

  • Cost-effectiveness
  • Critical care
  • Economics
  • End of life
  • ICU
  • Intensivists
  • Managing death
  • Mortality
  • Outcome
  • Resource utilization

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Pronovost, P., & Angus, D. C. (2001). Economics of end-of-life care in the intensive care unit. Critical Care Medicine, 29(2 SUPPL.).

Economics of end-of-life care in the intensive care unit. / Pronovost, P.; Angus, D. C.

In: Critical Care Medicine, Vol. 29, No. 2 SUPPL., 2001.

Research output: Contribution to journalArticle

Pronovost, P & Angus, DC 2001, 'Economics of end-of-life care in the intensive care unit', Critical Care Medicine, vol. 29, no. 2 SUPPL..
Pronovost, P. ; Angus, D. C. / Economics of end-of-life care in the intensive care unit. In: Critical Care Medicine. 2001 ; Vol. 29, No. 2 SUPPL.
@article{9959fcc23c8a4e8bb72db6503e8891bb,
title = "Economics of end-of-life care in the intensive care unit",
abstract = "End-of life care is in need of improvement, yet little is known about the effectiveness or cost of various end-of-life therapies. Economic analyses are used to help make decisions between two or more therapies when resources are constrained. In this chapter, we review the various types of economic analyses, the costs of dying, and how healthcare reform has impacted these costs. Finally, we discuss the unique issues associated with cost-effectiveness studies of palliative therapy, with emphasis on the problem of calculating a cost-effectiveness ratio when there is no good measurement for valuing the quality of death. It is likely that methods for conducting a cost-effectiveness analyses for end-of-life care will need to evolve or alternative strategies such as cost-benefit analysis or distributive justice will be needed to inform resource allocation decisions. As the national debate about healthcare costs, access, and quality continues, we will increasingly turn to economic analyses to help make resource allocation decisions. Cost-effectiveness analysis will continue to be the most popular form of economic analysis because it combines the results (effectiveness of treatment) with the costs of achieving the results. We must be aware of the limitations of cost-effectiveness analyses and the need for value judgments when using cost-effectiveness analyses to inform healthcare decisions.",
keywords = "Cost-effectiveness, Critical care, Economics, End of life, ICU, Intensivists, Managing death, Mortality, Outcome, Resource utilization",
author = "P. Pronovost and Angus, {D. C.}",
year = "2001",
language = "English (US)",
volume = "29",
journal = "Critical Care Medicine",
issn = "0090-3493",
publisher = "Lippincott Williams and Wilkins",
number = "2 SUPPL.",

}

TY - JOUR

T1 - Economics of end-of-life care in the intensive care unit

AU - Pronovost, P.

AU - Angus, D. C.

PY - 2001

Y1 - 2001

N2 - End-of life care is in need of improvement, yet little is known about the effectiveness or cost of various end-of-life therapies. Economic analyses are used to help make decisions between two or more therapies when resources are constrained. In this chapter, we review the various types of economic analyses, the costs of dying, and how healthcare reform has impacted these costs. Finally, we discuss the unique issues associated with cost-effectiveness studies of palliative therapy, with emphasis on the problem of calculating a cost-effectiveness ratio when there is no good measurement for valuing the quality of death. It is likely that methods for conducting a cost-effectiveness analyses for end-of-life care will need to evolve or alternative strategies such as cost-benefit analysis or distributive justice will be needed to inform resource allocation decisions. As the national debate about healthcare costs, access, and quality continues, we will increasingly turn to economic analyses to help make resource allocation decisions. Cost-effectiveness analysis will continue to be the most popular form of economic analysis because it combines the results (effectiveness of treatment) with the costs of achieving the results. We must be aware of the limitations of cost-effectiveness analyses and the need for value judgments when using cost-effectiveness analyses to inform healthcare decisions.

AB - End-of life care is in need of improvement, yet little is known about the effectiveness or cost of various end-of-life therapies. Economic analyses are used to help make decisions between two or more therapies when resources are constrained. In this chapter, we review the various types of economic analyses, the costs of dying, and how healthcare reform has impacted these costs. Finally, we discuss the unique issues associated with cost-effectiveness studies of palliative therapy, with emphasis on the problem of calculating a cost-effectiveness ratio when there is no good measurement for valuing the quality of death. It is likely that methods for conducting a cost-effectiveness analyses for end-of-life care will need to evolve or alternative strategies such as cost-benefit analysis or distributive justice will be needed to inform resource allocation decisions. As the national debate about healthcare costs, access, and quality continues, we will increasingly turn to economic analyses to help make resource allocation decisions. Cost-effectiveness analysis will continue to be the most popular form of economic analysis because it combines the results (effectiveness of treatment) with the costs of achieving the results. We must be aware of the limitations of cost-effectiveness analyses and the need for value judgments when using cost-effectiveness analyses to inform healthcare decisions.

KW - Cost-effectiveness

KW - Critical care

KW - Economics

KW - End of life

KW - ICU

KW - Intensivists

KW - Managing death

KW - Mortality

KW - Outcome

KW - Resource utilization

UR - http://www.scopus.com/inward/record.url?scp=0035116748&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035116748&partnerID=8YFLogxK

M3 - Article

VL - 29

JO - Critical Care Medicine

JF - Critical Care Medicine

SN - 0090-3493

IS - 2 SUPPL.

ER -